Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_assertion type Assertion NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_head.
- NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_assertion description "[These results indicate that EpCAM could contribute substantially to the pathogenesis of lung cancer, especially cancer cell survival, and suggest that EpCAM targeted therapy for lung cancer may have potential.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_provenance.
- NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_assertion evidence source_evidence_literature NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_provenance.
- NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_assertion SIO_000772 21535318 NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_provenance.
- NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_assertion wasDerivedFrom befree-20140225 NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_provenance.
- NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_assertion wasGeneratedBy ECO_0000203 NP615235.RAyDU2l6WIRUjUb6Az4J620ZBUkxlIXzv3_0B7eQgnLQ8130_provenance.